Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Cardiol Angeiol (Paris) ; 63(2): 107-10, 2014 Apr.
Article in French | MEDLINE | ID: mdl-22260907

ABSTRACT

AIM: The aim of this case report was to show the importance to research metabolic etiology, especially a carnitine deficiency in dilated cardiomyopathy of children. CASE REPORT: A three years old Togolese child presented muscular hypotonia, dyspnea. Examination showed left galop murmur and systolic murmur 2/6. Chest X-ray showed cardiomegaly (CTI: 0.66), electrocardiogram, a sinusal rythm, left ventricle hypertrophy and T wave abnormalities. Echocardiogram showed a markedly dilated left ventricle with reduced systolic function (EF: 0.43; reference range 0.55-0.80) and moderate mitral regurgitation. The inflammatory signs where negatives. Magnetic resonance imaging don't show signs of ischemic or myocarditis. The levels of free and total plasmatic carnitine decreased: 3µmol/L (N: 18-48µmol/L) and 5µmol/l (N: 29-70µmol/L) respectively. Mutation analysis of the gene SLC22A5 confirms the diagnosis of primary systemic carnitine deficiency. Treatment with oral carnitine was started at 200mg/kg per day. Within three weeks of treatment, we observed the decrease of all symptoms and the left ventricular size and function normalized (EF: 0.62). He has now been on oral carnitine for live. CONCLUSION: Primary carnitine deficiency is a cause of dilated cardiomyopathy in child. It must systematically be suspected when a child presents a primitive cardiomyopathy. The treatment with oral carnitine for live is simple, with excellent prognosis.


Subject(s)
Cardiomyopathies/genetics , Cardiomyopathy, Dilated/genetics , Carnitine/deficiency , Hyperammonemia/genetics , Muscular Diseases/genetics , Mutation , Organic Cation Transport Proteins/genetics , Biomarkers/blood , Cardiomyopathies/complications , Cardiomyopathies/diagnosis , Cardiomyopathies/drug therapy , Cardiomyopathy, Dilated/diagnosis , Cardiomyopathy, Dilated/drug therapy , Cardiomyopathy, Dilated/etiology , Carnitine/administration & dosage , Carnitine/genetics , Carnitine/therapeutic use , Child, Preschool , Dyspnea/etiology , Humans , Hyperammonemia/complications , Hyperammonemia/diagnosis , Hyperammonemia/drug therapy , Male , Muscular Diseases/complications , Muscular Diseases/diagnosis , Muscular Diseases/drug therapy , Prognosis , Solute Carrier Family 22 Member 5 , Time Factors , Treatment Outcome , Vitamin B Complex/administration & dosage , Vitamin B Complex/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...